Loading...

BJDX BLUEJAY DIAGNOSTICS INC Expansion Plans 8-K Filing

BLJY

BJDX

BLUEJAY DIAGNOSTICS INC

(BJDX)

2025 8-K

Quarterly Update

Stock Offering Update

Agreement Update

Board Appointments

Reverse Stock Split

Warrant Agreement

Nasdaq Compliance

Stock Split Approval

Bylaw Amendment

Nasdaq Compliance

Shareholder Meeting

Reverse Stock Split

Investment Agreement

Amendment to Certificate of...

Termination of Agreement an...

Public Offering

Clinical Study Initiation

Financial Results Announcement

Agreement with Toray Indust...

Departure of Directors

Earnings Reports

Compliance Regained

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Amendment to Employment Agr...

External Links:

On October 3, 2025, Bluejay Diagnostics, Inc. amended its agreements with Sanyoseiko to expand their role in commercializing the Symphony platform, focusing on rapid testing in sepsis management.

AI Assistant

BLUEJAY DIAGNOSTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.